We are live on ! Find out more
OCM

Osterweis Capital Management Portfolio holdings

AUM $2.12B
1-Year Est. Return 32.36%
This Fund
S&P 500
This Quarter Est. Return
+13.73%
1 Year Est. Return
+32.36%
3 Year Est. Return
+93.72%
5 Year Est. Return
+113.14%
10 Year Est. Return
+557.09%
AUM
$1.6B
AUM Growth
+$298M
Cap. Flow
-$220M
Cap. Flow %
-13.75%
Top 10 Hldgs %
34.46%
Holding
118
New
22
Increased
20
Reduced
40
Closed
12

Sector Composition

Rank Sector Weight
1 Miscellaneous 25.39%
2 Industrials 13.41%
3 Technology 13.15%
4 Healthcare 12.4%
5 Financials 8.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNKO icon
51
Funko
FNKO
$299M
$6.52M 0.41%
300,155
-83,745
-22% -$1.54M
BEAT
52
DELISTED
BioTelemetry, Inc.
BEAT
$6.42M 0.4%
102,530
+7,465
+8% +$513K
FOLD
53
DELISTED
Amicus Therapeutics
FOLD
$6.24M 0.39%
+458,830
New +$5.6M
TRHC
54
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$6.14M 0.38%
+108,910
New +$6.49M
AX icon
55
Axos Financial
AX
$5.26B
$5.92M 0.37%
204,535
+9,050
+5% +$271K
SKY icon
56
Champion Homes
SKY
$4.59B
$5.91M 0.37%
+311,000
New +$5.7M
VCEL icon
57
Vericel Corp
VCEL
$2.03B
$5.33M 0.33%
+304,645
New +$5.57M
CRCM
58
DELISTED
CARE.COM, INC.
CRCM
$5M 0.31%
252,915
+125,015
+98% +$2.81M
BOLD
59
DELISTED
Audentes Therapeutics, Inc
BOLD
$4.94M 0.31%
126,515
-29,135
-19% -$835K
TREX icon
60
Trex
TREX
$4.44B
$4.67M 0.29%
151,690
-101,970
-40% -$3.56M
XENT
61
DELISTED
Intersect ENT, Inc
XENT
$4.03M 0.25%
+125,190
New +$3.87M
GOOGL icon
62
Alphabet (Google) Class A
GOOGL
$4.22T
$3.94M 0.25%
66,880
+4,440
+7% +$251K
CDNA icon
63
CareDx
CDNA
$2.72B
$3.79M 0.24%
120,290
-88,260
-42% -$2.57M
IOVA icon
64
Iovance Biotherapeutics
IOVA
$4.24B
$3.7M 0.23%
+388,995
New +$3.78M
FND icon
65
Floor & Decor
FND
$4.91B
$3.67M 0.23%
88,915
-27,520
-24% -$966K
MED icon
66
Medifast
MED
$134M
$3.47M 0.22%
27,175
+4,565
+20% +$579K
EHTH icon
67
eHealth
EHTH
$28.5M
$3.4M 0.21%
+54,585
New +$3.01M
INSP icon
68
Inspire Medical Systems
INSP
$2.16B
$3.12M 0.2%
54,997
-14,660
-21% -$792K
LLY icon
69
Eli Lilly
LLY
$1.01T
$3.07M 0.19%
23,639
PG icon
70
Procter & Gamble
PG
$341B
$2.88M 0.18%
27,668
-560
-2% -$54.5K
TREE icon
71
LendingTree
TREE
$376M
$2.47M 0.15%
+7,020
New +$2.12M
KOD icon
72
Kodiak Sciences
KOD
$2.07B
$2.14M 0.13%
327,213
+2,700
+0.8% +$20K
BRK.A icon
73
Berkshire Hathaway Class A
BRK.A
$1.1T
$2.11M 0.13%
7
XOM icon
74
ExxonMobil
XOM
$696B
$1.93M 0.12%
23,901
-306
-1% -$23.3K
AAPL icon
75
Apple
AAPL
$4.84T
$1.79M 0.11%
37,788
+2,696
+8% +$114K

Similar funds

Osterweis Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Osterweis Capital Management held 118 positions worth $1.6B, up 23% from $1.3B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Osterweis Capital Management withdrew a net $220M in Q1 2019, closing 12 positions and reducing 40 holdings. Its most notable exit was JPMorgan Chase, an estimated $23.8M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Industrials and Technology.

Against the trend, Osterweis Capital Management opened a new position in Unilever NV New York Registry Shares worth $24.9M.

  • Osterweis Capital Management's largest Q1 2019 buy was Unilever NV New York Registry Shares: 427,550 shares worth $24.9M.
  • Osterweis Capital Management added most to Antero Midstream in Q1 2019, an estimated $9.55M increase.
  • Osterweis Capital Management's biggest Q1 2019 reduction was Hologic, cutting an estimated $7.11M.
  • Osterweis Capital Management fully exited JPMorgan Chase in Q1 2019, selling an estimated $23.8M.
  • Osterweis Capital Management's ten largest holdings make up 34% of its $1.6B portfolio in Q1 2019.
  • Osterweis Capital Management opened 22 new positions and closed 12 in Q1 2019.
  • Osterweis Capital Management's portfolio value rose 23% quarter-over-quarter to $1.6B.

Based on Osterweis Capital Management's 13F filing for Q1 2019, filed 15 May 2019.